Topic: How To Invest

Power Growth Investor Hotline – Thursday, June 30, 2022

Article Excerpt

MERCK & CO. INC., $91.97, is a buy. The drugmaker (symbol MRK on New York) is a pharmaceutical leader in oncology, acute-care and animal health drugs as well as vaccines. Merck is now launching Merck Digital Sciences Studio (MDSS) to promote new innovative technologies for drug discovery and development. MDSS will support early-stage biomedical startups with direct investment, access to Azure Cloud computing and opportunities to move forward their technologies in collaboration with discovery and clinical scientists at Merck. Merck will start by partnering with two startups. Those developing artificial intelligence (AI) and machine learning (ML) applications will be prioritized. The company believes that the biopharmaceutical industry has only just started to harness the big opportunities presented by emerging technological developments in artificial intelligence (AI) and machine learning. The MDSS is a collaboration between Merck and the New Jersey Innovation Institute (NJII), a New Jersey Institute of Technology corporation. Technology support will be provided by Microsoft for Startups. The MDSS will have locations in Newark,…